For the Inventor, By the Inventor

Enter assignee name

Kenilworth, NJ, United States of America

Key Pharmaceuticals, Inc.

USPTO Granted Patents = 54

CIPO Patents = 2

Trademarks = 1

Forward Citations = 2,928

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Alec D Keith (22 out of 28 patents)

Wallace Snipes (15 out of 16 patents)

Charles H Hsiao (7 out of 9 patents)

4. Nicholas S Bodor (6 out of 86 patents)

5. Ronald R Tuttle (6 out of 7 patents)

6. Thorsteinn Loftsson (4 out of 27 patents)

7. Marvin A Sackner (3 out of 38 patents)

8. Allyn L Golub (3 out of 3 patents)

9. Steven Sablotsky (2 out of 17 patents)

10. Peter C Meltzer (1 out of 30 patents)

11. John M Questel (1 out of 6 patents)

12. James A Thompson (1 out of 2 patents)

13. Herman L Watson (1 out of 14 patents)

14. Arthur M Harris (1 out of 6 patents)

15. Julius Diamond (1 out of 76 patents)

Core Competencies:

Transdermal Dosage Forms

Controlled Release Formulations

Percutaneous Penetration Enhancers

Polymeric Diffusion Matrices

Drug Delivery Methods

Sustained Release Tablets

Iontophoretic Drug Delivery

Bronchospastic Airway Treatment

Intrapulmonary Drug Delivery

Hyperkinetic Child Treatment

Anti-Spilling Drug Capsules

Pheromone Delivery Systems

54 patents: Sort by Forward Citations

1. 5186938 - Adhesive transdermal dosage layer (1993-02-16),

2. 4983396 - Percutaneous penetration enhancer of oleic acid and (1991-01-08),

3. 4885174 - Percutaneous penetration enhancer of oleic acid and (1989-12-05),

4. 4863743 - Controlled release potassium chloride (1989-09-05),

5. 4859707 - Sulfur-substituted phenylacetamides (1989-08-22),

6. 4764381 - Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, (1988-08-16),

7. 4722726 - Method and apparatus for iontophoretic drug delivery (1988-02-02),

8. 4708867 - Minipellets (1987-11-24),

9. 4689213 - Method and composition for treating bronchospastic airway diseases (1987-08-25),

10. 4679555 - Method and apparatus for intrapulmonary delivery of heparin (1987-07-14),

11. 4639455 - Means of aiding in the prevention of sudden infant death syndrome (1987-01-27),

12. 4634587 - Sustained release quinidine dosage form (1987-01-06),

13. 4594356 - Method for inducing mydriasis in animals (1986-06-10),

14. 4587118 - Dry sustained release theophylline oral formulation (1986-05-06),

15. 4585452 - Transdermal systemic dosage forms (1986-04-29),

Key Pharmaceuticals, Inc. is a leading global pharmaceutical company specializing in the research, development, and production of innovative and life-saving medications. With a strong focus on improving patients' lives, Key Pharmaceuticals is committed to delivering high-quality and accessible healthcare solutions. Our dedicated team of scientists, researchers, and professionals work tirelessly to develop cutting-edge treatments for various diseases and medical conditions. Through collaborations and strategic partnerships, we strive to make a positive impact on the healthcare industry and contribute to the well-being of people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

54 Patents

#2 in Kenilworth, NJ

#266 in New Jersey

#6,342 in US

#12,735 in the World

Kenilworth, NJ, United States of America

Key Pharmaceuticals, Inc.

Forward Citations = 2,928

25 inventors:

Alec D Keith (22 out of 28 patents)

Wallace Snipes (15 out of 16 patents)

Charles H Hsiao (7 out of 9 patents)

4. Nicholas S Bodor (6 out of 86 patents)

5. Ronald R Tuttle (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…